Logo image of BENF

BENEFICIENT - CLASS A (BENF) Stock Fundamental Analysis

NASDAQ:BENF - Nasdaq - US08178Q3092 - Common Stock - Currency: USD

0.313  +0.01 (+2.62%)

After market: 0.315 +0 (+0.64%)

Fundamental Rating

1

Taking everything into account, BENF scores 1 out of 10 in our fundamental rating. BENF was compared to 223 industry peers in the Capital Markets industry. BENF may be in some trouble as it scores bad on both profitability and health. BENF is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year BENF has reported negative net income.
In the past year BENF has reported a negative cash flow from operations.
BENF had negative earnings in each of the past 5 years.
BENF had a negative operating cash flow in each of the past 5 years.
BENF Yearly Net Income VS EBIT VS OCF VS FCFBENF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -500M -1B -1.5B -2B

1.2 Ratios

BENF has a worse Return On Assets (-3.57%) than 82.67% of its industry peers.
Industry RankSector Rank
ROA -3.57%
ROE N/A
ROIC N/A
ROA(3y)-192.54%
ROA(5y)-115.94%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BENF Yearly ROA, ROE, ROICBENF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 500 -500

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for BENF so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BENF Yearly Profit, Operating, Gross MarginsBENF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 500 1K 1.5K 2K

More info and screens

0

2. Health

2.1 Basic Checks

The number of shares outstanding for BENF has been reduced compared to 1 year ago.
The debt/assets ratio for BENF is higher compared to a year ago.
BENF Yearly Shares OutstandingBENF Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M 20M
BENF Yearly Total Debt VS Total AssetsBENF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

BENF has an Altman-Z score of -8.22. This is a bad value and indicates that BENF is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -8.22, BENF is not doing good in the industry: 93.33% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -8.22
ROIC/WACCN/A
WACCN/A
BENF Yearly LT Debt VS Equity VS FCFBENF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

A Current Ratio of 0.03 indicates that BENF may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.03, BENF is doing worse than 94.67% of the companies in the same industry.
A Quick Ratio of 0.03 indicates that BENF may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.03, BENF is doing worse than 94.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.03
Quick Ratio 0.03
BENF Yearly Current Assets VS Current LiabilitesBENF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 97.24% over the past year.
BENF shows a strong growth in Revenue. In the last year, the Revenue has grown by 73.14%.
EPS 1Y (TTM)97.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.57%
Revenue 1Y (TTM)73.14%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%143.18%

3.2 Future

BENF is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.02% yearly.
BENF is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 50.44% yearly.
EPS Next Y99.48%
EPS Next 2Y41.38%
EPS Next 3Y26.02%
EPS Next 5YN/A
Revenue Next Year147.32%
Revenue Next 2Y57.48%
Revenue Next 3Y50.44%
Revenue Next 5YN/A

3.3 Evolution

BENF Yearly Revenue VS EstimatesBENF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 50M -50M 100M -100M
BENF Yearly EPS VS EstimatesBENF Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 -1 -2 -3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BENF. In the last year negative earnings were reported.
Also next year BENF is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BENF Price Earnings VS Forward Price EarningsBENF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BENF Per share dataBENF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -5 -10 -15 -20

4.3 Compensation for Growth

A more expensive valuation may be justified as BENF's earnings are expected to grow with 26.02% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.38%
EPS Next 3Y26.02%

More info and screens

0

5. Dividend

5.1 Amount

BENF does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BENEFICIENT - CLASS A

NASDAQ:BENF (3/7/2025, 8:07:10 PM)

After market: 0.315 +0 (+0.64%)

0.313

+0.01 (+2.62%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)02-13 2025-02-13/bmo
Earnings (Next)N/A N/A
Inst Owners12.8%
Inst Owner Change0%
Ins Owners8.34%
Ins Owner Change11.8%
Market Cap2.71M
AnalystsN/A
Price Target4.08 (1203.51%)
Short Float %5.65%
Short Ratio0.8
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)63.14%
Min EPS beat(2)26.66%
Max EPS beat(2)99.62%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1332.87%
Min Revenue beat(2)-50.76%
Max Revenue beat(2)2716.49%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-20%
PT rev (3m)-20%
EPS NQ rev (1m)6.11%
EPS NQ rev (3m)31.09%
EPS NY rev (1m)-69.55%
EPS NY rev (3m)-69.55%
Revenue NQ rev (1m)-0.05%
Revenue NQ rev (3m)4076.29%
Revenue NY rev (1m)4.81%
Revenue NY rev (3m)140.54%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-20.06
EYN/A
EPS(NY)-0.71
Fwd EYN/A
FCF(TTM)-4.54
FCFYN/A
OCF(TTM)-4.38
OCFYN/A
SpS-2.3
BVpS-19.24
TBVpS-20.74
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.57%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-192.54%
ROA(5y)-115.94%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover-0.05
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 70.41%
Cap/Sales -7.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.03
Quick Ratio 0.03
Altman-Z -8.22
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)101.07%
Cap/Depr(5y)N/A
Cap/Sales(3y)16.52%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)97.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.57%
EPS Next Y99.48%
EPS Next 2Y41.38%
EPS Next 3Y26.02%
EPS Next 5YN/A
Revenue 1Y (TTM)73.14%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%143.18%
Revenue Next Year147.32%
Revenue Next 2Y57.48%
Revenue Next 3Y50.44%
Revenue Next 5YN/A
EBIT growth 1Y56.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y62.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y63.13%
OCF growth 3YN/A
OCF growth 5YN/A